doi:10.3969/j.issn.1673-8640.2021.07.010

Abstract

CLC Number:

R446.1

Figures/Tables 2

References 7

[1]	龚如涵, 刘庆中, 陈沭, 等. 上海市松江区0~12岁上呼吸道感染患儿7种常见病毒流行病学特征[J]. 检验医学, 2019, 34(12):1097-1100.
[2]	张耘实, 祁贤, 卢协勤, 等. 栀子苷对甲型H1N1流感病毒的抑制作用[J]. 中国药科大学学报, 2016, 47(2):204-209.
[3]	贺凤兰, 刘强, 刘媛媛, 等. 欧意清热解毒软胶囊体外抗甲型H1N1流感病毒作用[J]. 中国中药杂志, 2011, 36(14):1993-1996.
[4]	WU Q F, ZHU W R, YAN Y L, et al. Anti-H1N1 influenza effects and its possible mechanism of Huanglian Xiangru Decoction[J]. J Ethnopharmacol, 2016, 185:282-288. DOI URL
[5]	肖四方, 潘建华, 向延根. NLR、PLR和LMR在急诊甲、乙型流感病毒感染者中的临床意义[J]. 热带医学杂志, 2018, 18(11):1478-1481.
[6]	SCHWEIGER B, ZADOW I, HECKLER R, et al. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples[J]. J Clin Microbiol, 2000, 38(4):1552-1558. DOI URL
[7]	李雪辉, 吕楠, 陈杭薇, 等. 229例成人甲型流感患者临床特征分析[J]. 国际呼吸杂志, 2011, 31(14):1041-1043.

组别	例数	白细胞计数（×10⁹/L）	中性粒细胞百分比/%	淋巴细胞百分比/%	NLR	CRP/ （mg/L）
甲型流感组	131	6.52±0.17^*	78.42±0.68	12.17±0.54	8.85±0.52^*#	17.88±1.28^*
乙型流感组	63	6.07±0.30^*	78.45±10.06	20.27±1.29	5.17±0.60	12.49±1.44^**
对照组	100	7.61±0.35	71.30±1.41	19.65±1.14	5.72±0.49	29.62±3.77
F值		6.060 0	1.156 0	3.223 0	13.027 0	9.404 0
P值		0.000 5	0.031 6	<0.000 1	<0.000 1	<0.000 1

组别	例数	白细胞计数（×10⁹/L）	中性粒细胞百分比/%	淋巴细胞百分比/%	NLR	CRP/ （mg/L）
甲型流感组	131	6.52±0.17^*	78.42±0.68	12.17±0.54	8.85±0.52^*#	17.88±1.28^*
乙型流感组	63	6.07±0.30^*	78.45±10.06	20.27±1.29	5.17±0.60	12.49±1.44^**
对照组	100	7.61±0.35	71.30±1.41	19.65±1.14	5.72±0.49	29.62±3.77
F值		6.060 0	1.156 0	3.223 0	13.027 0	9.404 0
P值		0.000 5	0.031 6	<0.000 1	<0.000 1	<0.000 1

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 7

Related Articles 15

Recommended Articles

Metrics